Clinical characteristics of challenging catheter ablation procedures in patients with WPW syndrome: A 10 year single-center experience.

Journal of cardiology
Tadashi FujinoLeonardo Calò

Abstract

Catheter ablation is the established treatment for patients with symptomatic Wolff-Parkinson-White syndrome (WPW). However, some patients undergo a challenging ablation or have recurrences during the early post-ablation phase. The aim of this study was to evaluate the clinical factors associated with an unsuccessful ablation outcome or repeated sessions. Four hundred seventy-five symptomatic consecutive WPW patients (38.2±16.2 years old, 61% men, 69% with pre-excitation) who underwent an accessory pathway (AP) ablation from August 2005 to December 2015 were enrolled. When APs recurred, a redo ablation procedure was performed according to the patients' desire. Four hundred thirty-nine patients (92.4%) were cured by ablation, but it failed in 36 (7.6%) after the first procedure. Seventeen patients had AP recurrences during the acute phase within 36h post-ablation. On the other hand, 4 were identified after more than one year. In a multivariate logistic regression analysis, multiple, parahisian, and broad APs were significant independent predictors of recurrences after the 1st procedure, with odds ratios of 14.88 (p<0.001), 10.14 (p<0.001), and 6.88 (p<0.001), respectively. Finally, 468 patients (98.5%) received a successful ablat...Continue Reading

References

Nov 1, 1991·Pacing and Clinical Electrophysiology : PACE·N TwidaleW M Jackman
Sep 1, 1990·Journal of the American College of Cardiology·H J WellensP Brugada
Sep 1, 1995·The American Journal of Cardiology·C TimmermansH J Wellens
Dec 1, 1994·British Heart Journal·C TimmermansH J Wellens
May 15, 1993·The American Journal of Cardiology·S J YehD Wu
Mar 1, 1996·Journal of the American College of Cardiology·F MoradyF Bogun
Jul 24, 2002·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Pedro IturraldeLuis Colin
Apr 18, 2003·Pacing and Clinical Electrophysiology : PACE·Melvin ScheinmanUNKNOWN North American Society of Pacing and Electrophysiology
Aug 2, 2003·Journal of Cardiovascular Electrophysiology·Fiorenzo GaitaPierre Jais
Mar 13, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Frederic SacherMichel Haissaguerre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Related Papers

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Frederic SacherM Haïssaguerre
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Andrzej GłowniakAndrzej Wysokiński
© 2022 Meta ULC. All rights reserved